Suppr超能文献

γ-氨基丁酸A受体的内酯调节:存在正向调节位点的证据。

Lactone modulation of the gamma-aminobutyric acid A receptor: evidence for a positive modulatory site.

作者信息

Williams K L, Tucker J B, White G, Weiss D S, Ferrendelli J A, Covey D F, Krause J E, Rothman S M

机构信息

Department of Anatomy and Neurobiology, Washington University School of Medicine, Saint Louis, Missouri 63110, USA.

出版信息

Mol Pharmacol. 1997 Jul;52(1):114-9. doi: 10.1124/mol.52.1.114.

Abstract

The gamma-aminobutyric acid-A (GABA(A)) receptor complex is allosterically modulated by a variety of substances, some of clinical importance. Barbiturates and neurosteroids augment GABA-currents and also directly gate the channel. A variety of gamma-butyrolactone analogues also modulate GABA-induced currents, with some potentiating and others inhibiting. Because several gamma-thiobutyrolactone analogues have biphasic effects on GABA currents, experiments with wild-type and picrotoxinin-insensitive GABA(A) receptors were performed to analyze whether some gamma-thiobutyrolactones interact with two distinguishable sites on the GABA(A) receptor. beta-Ethyl-beta-methyl-gamma-thiobutyrolactone inhibited GABA-induced currents at low concentrations (0.001-1 mM), but potentiated GABA-induced currents at higher concentrations (3-10 mM) in wild-type alpha1beta2gamma2-subunit containing ionophores. The related alpha-ethyl-alpha-methyl-gamma-thiobutyrolactone potentiated submaximal GABA currents in wild-type receptors at both low and high concentrations (0.1-10 mM). Mutations in the second transmembrane domain of alpha1, beta2, or gamma2 conferred picrotoxinin-insensitivity onto GABA(A) receptor complexes. When these mutated alpha1, beta2, or gamma2 subunits were incorporated into the receptor complex, beta-ethyl-beta-methyl-gamma-thiobutyrolactone potentiated GABA currents over the entire concentration range (0.1-10 mM). Neither the potentiating activity nor the EC50 of alpha-ethyl-alpha-methyl-gamma-thiobutyrolactone changed in the mutant receptors. Further studies demonstrated that the mutations did not affect the EC50 of chlordiazepoxide or phenobarbital. These and our earlier results identify a modulatory site on the GABA(A) receptor distinct from that interacting with barbiturates, benzodiazepines, and steroids. Additionally, they show that the gamma-butyrolactones probably interact at two different sites on the ionophore to produce opposite effects on GABA-mediated current.

摘要

γ-氨基丁酸A(GABA(A))受体复合物受到多种物质的变构调节,其中一些具有临床重要性。巴比妥类药物和神经甾体增强GABA电流,并且还直接控制通道。多种γ-丁内酯类似物也调节GABA诱导的电流,有些具有增强作用,有些则具有抑制作用。由于几种γ-硫代丁内酯类似物对GABA电流具有双相作用,因此进行了野生型和对印防己毒素不敏感的GABA(A)受体实验,以分析某些γ-硫代丁内酯是否与GABA(A)受体上两个可区分的位点相互作用。β-乙基-β-甲基-γ-硫代丁内酯在低浓度(0.001-1 mM)时抑制GABA诱导的电流,但在含有野生型α1β2γ2亚基的离子载体中,在较高浓度(3-10 mM)时增强GABA诱导的电流。相关的α-乙基-α-甲基-γ-硫代丁内酯在野生型受体中,无论低浓度还是高浓度(0.1-10 mM),都能增强亚最大GABA电流。α1、β2或γ2的第二个跨膜结构域中的突变使GABA(A)受体复合物对印防己毒素不敏感。当这些突变的α1、β2或γ2亚基被整合到受体复合物中时,β-乙基-β-甲基-γ-硫代丁内酯在整个浓度范围(0.1-10 mM)内增强GABA电流。在突变受体中,α-乙基-α-甲基-γ-硫代丁内酯的增强活性和EC50均未改变。进一步的研究表明,这些突变不影响氯氮卓或苯巴比妥的EC50。这些以及我们早期的结果确定了GABA(A)受体上一个与巴比妥类药物、苯二氮卓类药物和甾体相互作用位点不同的调节位点。此外,它们表明γ-丁内酯可能在离子载体上的两个不同位点相互作用,从而对GABA介导的电流产生相反的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验